Neuroleptic-opiod interaction: Relevance to tardive dyskinesia

References

• American Psychiatric Association. Tardive dyskinesia. Washington, D.C. 1980
   Google Scholar
• Baldessarini R. J., Tarsy D. Relationship of the actions of neuroleptic drugs to the pathophysiology of the tardive dyskinesia. International Review Neurolobiology 1979; 21: 1–45
   Google Scholar
• Bissio G., Casu M., Corda M. G., Di Bello C., Gessa G. L. Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone. Science 1978; 200(4341)552–554
   Google Scholar
• Bloom F., Segal D., Ling N., Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 1976; 194(4256)630–632
   Google Scholar
• Bloom F., Battenberg E., Rossier J., Ling N., Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin; immunocytochemical studies. Proceedings National Academy of Sciences, U.S.A. 1978; 75(3)1591–1595
   PubMedGoogle Scholar
• Blum I., Elizur A., Segal A., Ochshorn N., Stimantov R. Effect of naloxone on the neuropsychiatric systems of a woman with partial adrenal 21-hydroxylase deficiency. American Journal Psychiatry 1984; 140(8)1058–1060
   Google Scholar
• Blum I., Munitz N., Shalev A., Roberts E. Naloxone may be beneficial in the treatment of tardive dyskinesia. Clinical Neuropharmacology 1984; 7(3)265–267
   Google Scholar
• Burke R. E. Tardive dyskinesia: current clinical issues. Neurology 1984; 34(10)1348–1353
   Google Scholar
• Burt D. R., Creese I., Snyder S. H. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 1977; 196(4287)326–328
   PubMed Web of Science ®Google Scholar
• Chang K. J., Cooper N. R., Hazum E., Cuatrecasas P. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptices. Molecular Pharmacology 1979; 16(1)16, 91–104
   Google Scholar
• Clow A., Theodorou A., Jenner R., Marsden C. D. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. European Journal Pharmacology 1980; 63(2–3)145–157
   Google Scholar
• Costa E., Gnegy M. G., Uzunov P. Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase. Naunyn Schmiedebergs Archives Pharmacology 1977; 297(1)847–848
   Google Scholar
• Eibergen R. D., Carlson K. R. Dyskinesias elicited by methamphetamine: susceptibility of former methadone-consuming monkeys. Science 1975; 190(4214)588–590
   Google Scholar
• Fibiger H. C., Lloyd K. G. Neurological substrates of tardive dyskinesia: the GABA hypothesis. Trends in Neurological Science 1984; 1: 462–464
   Google Scholar
• Friedhoff A. J., Bonnet K., Tosengarten H. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa. Research Communications Chemical Pathology Pharmacology 1977; 16(3)411–423
   Google Scholar
• Gillman M. A., Sandyk R., Lichtigfeld F. J. Evidence for underactivity of the opioid system in neuroleptic-induced akathisia. Psychiatry Research 1984; 13(2)187
   Google Scholar
• Hong J. S., Yang H. Y., Fratta W., Costa E. Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. Journal Pharmacology Experimental Therapeutics 1978; 205(1)141–147
   Google Scholar
• Hong J. S., Yang H. Y., Gillin J. C., Di Giulio A. M., Fratta W., Costa E. Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Research 1979; 160(1)192–195
   Google Scholar
• Hong J. S., Yoshikawa K., Kanamatsu T., Sabol S. L. Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Federation Proceedings 1985; 44(9)2535–2539
   Google Scholar
• Klawans H. L., Tanner C. M., Barr A. The reversibility of permanent tardive dyskinesia. Clinical Neuropharmacology 1984; 7(2)153–159
   PubMed Web of Science ®Google Scholar
• Nutt J. G., Rosin A. J., Eisler T., Calne D. B., Chase T. N. Effect of an opiate antagonist on movement disorders. Archives Neurology 1978; 35(12)810–811
   Google Scholar
• Pollard H., Llorens C., Schwartz J. C., Gros C., Dray F. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Research 1978; 151(2)392–398
   Google Scholar
• Quitkin F., Rifkin A., Gochfeld L., Klein D. F. Tardive dyskinesia: are first signs reversible. American Journal Psychiatry 1977; 134(1)84–87
   PubMed Web of Science ®Google Scholar
• Sayers A. C., Burki H. R., Ruch W., Asper H. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia 1975; 41(2)97–104
   Google Scholar
• Seeger T. F., Nazzaro J. M., Gardner E. L. Selective inhibition of mesolimbic behavioral supersensitivity by naloxone. European Journal Pharmacology 1980; 65(4)435–438
   Google Scholar
• Segal D. S., Browne R. G., Bloom F., Ling N., Guillemin R. beta-Endorphin: endogenous opiate or neuroleptic. Science 1977; 198(4315)411–414
   Google Scholar
• Stahl S. M., Thornton J. E., Simpson M. L., Berger P. A., Napoliello M. J. Gammavinyl-GABA treatment of tardive dyskinesia and other movement disorders. Biological Psychiatry 1985; 20(2)888–893
   Google Scholar
• Stille G., Lauener H., Eichenberger E. The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b, e) (1,4) diazephine (clozapine). Farmacological Practice 1971; 26(10)603–625
   Google Scholar
• Stinus L., Winnock M., Kelley A. E. Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates. Psychopharmacology 1985; 85(3)323–328
   Google Scholar
• Tamminga C. A., Thaker G. K., Chase T. N. GABA dysfunction in the pathophysiology of tardive dyskinesia. Psychopharmacology 1985; 2: 122–127
   Google Scholar
• Walters A., Hening W., Chokroverty S. Opioid responsiveness of neuroleptic-induced akathisia. Annals Neurology 1985; 18(1)137
   Google Scholar
• Wasserman S., Yahr M. D. Choreic movements induced by the use of methadone. Archives Neurology 1980; 37(11)727–728
   PubMedGoogle Scholar